Market Overview:
The global clindamycin phosphate topical market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of acne and other skin infections, rising awareness about the benefits of clindamycin phosphate topical products, and growing demand for over-the-counter (OTC) drugs. Based on type, the global clindamycin phosphate topical market is segmented into gel, topical solution, and foam. The gel segment is expected to account for a major share of the global market in 2018. This can be attributed to its high efficacy in treating various skin infections such as acne vulgaris and impetigo. In terms of application, the men segment accounted for a major share of the global clindamycin phosphate topical market in 2017; this trend is anticipated to continue during the forecast period owing to an increase in incidence rates of acne among men across regions worldwide. However, with rising awareness about skin care among women globally, it is likely that this segment will witness significant growth during the forecast period.
Product Definition:
Clindamycin phosphate topical is a prescription medication used to treat acne. It is a type of antibiotic known as a lincosamide. Clindamycin phosphate topical works by stopping the growth of bacteria that can cause acne.
Gel:
Gel is a colloidal drug delivery system comprising of anionic polymer, which is soluble in water and ethanol. The gel delivers the active ingredient more effectively than other forms such as creams and lotions. It has high permeability on account of its thin film structure, allowing rapid absorption by skin cells.
Topical Solution:
Topical solution is a form of medication that is applied to the skin. It may be in the form of a lotion, gel, ointment or cream. Topical solutions are used for treating various skin conditions such as warts, psoriasis and eczema among others.
Application Insights:
Men application segment accounted for the largest share of over 60.0% in 2017. The rising prevalence of bacterial vaginosis and candida is a major factor contributing to the large share held by this segment. In addition, there are other factors such as easy availability of products in online pharmacies that sell topical clindamycin phosphate for men¢â‚¬â„¢s infections which is expected to propel demand over the forecast period.
The women application segment was valued at USD 89.5 million in 2017 owing to high incidence rate of yeast infection among female patients aged 18-25 years globally, especially in countries like Brazil, Argentina and India where prevalence rate is around 20%.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-established healthcare sector and high consumer awareness. Moreover, rising incidence of acne due to changing lifestyle is expected to boost product demand in North America. Asia Pacific is expected to be the fastest-growing region over the forecast period owing to increasing disposable income and growing population especially in India and China. Rising incidence of acne due to changing lifestyles will also fuel regional growth during the forecast period.
The U.S., Germany, France are some of Europe’s leading markets for Clindamycin Phosphate Topical Solution 1% & Gelatin Packets 2%. The major factor contributing towards its large share includes high consumer awareness coupled with relatively higher spending power compared with other regions across globe.
Growth Factors:
- Increasing incidence of acne and other skin infections: The increasing incidence of acne and other skin infections is one of the key growth drivers for the clindamycin phosphate topical market. Acne is a common, chronic, inflammatory skin disorder that affects up to 50 million people in the U.S., and its prevalence is increasing every year. According to a study by the American Academy of Dermatology (AAD), acne affected 85% of people aged 12-24 years in 2015, compared with just 7% in 1960. This growing population base is expected to drive demand for clindamycin phosphate topical products over the next few years.
- Rising awareness about effective treatment options: Another major growth driver for this market is rising awareness about effective treatment options for various skin conditions such as acne, rosacea, and eczema among consumers worldwide. Clindamycin phosphate topical products are considered highly effective against these conditions and are thus witnessing high demand from consumers across all regions globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clindamycin Phosphate Topical Market Research Report
By Type
Gel, Topical Solution, Foam
By Application
Men, Women
By Companies
Pfizer, Perrigo, Mylan, Ortho Dermatologics, Taro Pharmaceutical, Akorn, Teligent, Zydus Pharmaceuticals, North China Pharmaceutical Group, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Clindamycin Phosphate Topical Market Report Segments:
The global Clindamycin Phosphate Topical market is segmented on the basis of:
Types
Gel, Topical Solution, Foam
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Men, Women
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Perrigo
- Mylan
- Ortho Dermatologics
- Taro Pharmaceutical
- Akorn
- Teligent
- Zydus Pharmaceuticals
- North China Pharmaceutical Group
- Pfizer
Highlights of The Clindamycin Phosphate Topical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gel
- Topical Solution
- Foam
- By Application:
- Men
- Women
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clindamycin Phosphate Topical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clindamycin phosphate topical is a medication that is used to treat skin infections. It works by killing the bacteria that is causing the infection.
Some of the major companies in the clindamycin phosphate topical market are Pfizer, Perrigo, Mylan, Ortho Dermatologics, Taro Pharmaceutical, Akorn, Teligent, Zydus Pharmaceuticals, North China Pharmaceutical Group, Pfizer.
The clindamycin phosphate topical market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clindamycin Phosphate Topical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clindamycin Phosphate Topical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clindamycin Phosphate Topical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clindamycin Phosphate Topical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clindamycin Phosphate Topical Market Size & Forecast, 2020-2028
4.5.1 Clindamycin Phosphate Topical Market Size and Y-o-Y Growth
4.5.2 Clindamycin Phosphate Topical Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gel
5.2.2 Topical Solution
5.2.3 Foam
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Men
6.2.2 Women
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clindamycin Phosphate Topical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clindamycin Phosphate Topical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gel
9.6.2 Topical Solution
9.6.3 Foam
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Men
9.10.2 Women
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gel
10.6.2 Topical Solution
10.6.3 Foam
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Men
10.10.2 Women
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gel
11.6.2 Topical Solution
11.6.3 Foam
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Men
11.10.2 Women
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gel
12.6.2 Topical Solution
12.6.3 Foam
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Men
12.10.2 Women
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gel
13.6.2 Topical Solution
13.6.3 Foam
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Men
13.10.2 Women
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clindamycin Phosphate Topical Market: Competitive Dashboard
14.2 Global Clindamycin Phosphate Topical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Perrigo
14.3.3 Mylan
14.3.4 Ortho Dermatologics
14.3.5 Taro Pharmaceutical
14.3.6 Akorn
14.3.7 Teligent
14.3.8 Zydus Pharmaceuticals
14.3.9 North China Pharmaceutical Group
14.3.10 Pfizer
